Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

This study has been completed.

Study NCT00066196 Information provided by MedImmune LLC

First Received: August 5, 2003 Last Updated: January 14, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2007
Estimated Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)